ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1933 • 2019 ACR/ARP Annual Meeting

    Tumorigenesis Related Gene Identification in Dermatomyositis Using Meta-Analysis

    Jihad Aljabban1, Saad Syed 2, Sharjeel Syed 3, Kalyn Hoffman 4, Laith Hasan 5, Nikhil Adapa 1, Zahir Allarakhia 6, Dexter Hadley 7, Mohamad Aljabban 8 and Wael Jarjour 9, 1Ohio State University College of Medicine, Columbus, 2Stanford School of Medicine, Stanford, 3Stanford School of Medicine, Stanford, CA, 4The Ohio State University College of Medicine, Columbus, OH, 5Tulane School of Medicine, New Orleans, 6Ohio State University College of Medicine, Columbus, OH, 7Institute for Computational Health Sciences, San Francisco, 8Genesys Health Systems, Grand Blanc, MI, 9Ohio State College of Medicine, Columbus, OH

    Background/Purpose: Dermatomyositis (DM) is a progressive, systemic autoimmune disease-causing inflammatory changes in the skin and skeletal muscles.  DM is associated with carcinomas of the ovary,…
  • Abstract Number: 1934 • 2019 ACR/ARP Annual Meeting

    Tripartite Motif (TRIM) Gene Family Expression in Dermatomyositis

    Jihad Aljabban1, Sharjeel Syed 2, Saad Syed 3, Zarife Sahenk 4, Noah Weisleder 5, Kevin McElhanon 5, Kalyn Hoffman 6, Nikhil Adapa 1, Zahir Allarakhia 7, Laith Hasan 8, Dexter Hadley 9, Mohamad Aljabban 10 and Wael Jarjour 11, 1Ohio State University College of Medicine, Columbus, 2Stanford School of Medicine, Stanford, CA, 3Stanford School of Medicine, Stanford, 4Department of Neurology, Research Institute at Nationwide Children’s Hospital, Columbus, OH, 5Dorothy M. Davis Heart and Lung Research Institute & Dept. of Physiology & Cell Biology, The Ohio State University Wexner Medical Center, Columbus, OH, 6The Ohio State University College of Medicine, Columbus, OH, 7Ohio State University College of Medicine, Columbus, OH, 8Tulane School of Medicine, New Orleans, 9Institute for Computational Health Sciences, San Francisco, 10Genesys Health Systems, Grand Blanc, MI, 11Ohio State College of Medicine, Columbus, OH

    Background/Purpose: Dermatomyositis (DM) is a progressive, systemic autoimmune disease causing inflammatory changes to the skin and skeletal muscles. TRIM family proteins are composed of approximately…
  • Abstract Number: 1935 • 2019 ACR/ARP Annual Meeting

    Multi-Organ System Meta-Analytic Approach to Investigating Sarcoidosis

    Jihad Aljabban1, Saad Syed 2, Sharjeel Syed 3, Nikhil Adapa 1, Laith Hasan 4, Zahir Allarakhia 5, Dexter Hadley 6, Mohamad Aljabban 7 and Wael Jarjour 8, 1Ohio State University College of Medicine, Columbus, 2Stanford School of Medicine, Stanford, 3Stanford School of Medicine, Stanford, CA, 4Tulane School of Medicine, New Orleans, 5Ohio State University College of Medicine, Columbus, OH, 6Institute for Computational Health Sciences, San Francisco, 7Genesys Health Systems, Grand Blanc, MI, 8Ohio State College of Medicine, Columbus, OH

    Background/Purpose: Sarcoidosis (SD) is a granulomatous inflammatory disease with a heterogenous presentation and no definite etiology. SD usually begins in the lungs, skin, or lymph…
  • Abstract Number: 1936 • 2019 ACR/ARP Annual Meeting

    The Expression of the Interferon Inducible Gene SERPING1 Is Reduced by Rituximab and Correlates with Clinical Response in Systemic Lupus Erythematosus

    Liliana Santos Ribeiro1, Mariea Parvaz 2, Su-Ann Yeoh 2 and Michael Ehrenstein 2, 1University College London, London, United Kingdom, 2University College London, London, England, United Kingdom

    Background/Purpose: Abnormalities in B cells and the interferon alpha (IFN) pathway have been separately implicated in the pathogenesis of systemic lupus erythematosus (SLE). B cell…
  • Abstract Number: 1937 • 2019 ACR/ARP Annual Meeting

    Mononuclear Leukocyte DNA Methylome Imprinting of Networked Signaling and Immunity Regulatory Pathways in Gout

    Zengmiao Wang 1, Ying Zhao 1, Amanda Phipps-Green 2, Ru Liu-Bryan 3, Arnold Ceponis 1, David Boyle 4, Jun Wang 1, Tony Merriman 5, Wei Wang 4 and Robert Terkeltaub6, 1UCSD, La Jolla, CA, 2University of Otago, Otago, Otago, New Zealand, 3San Diego VA/UCSD, La Jolla, CA, 4University of California, San Diego, San Diego, CA, 5University of Otago, Birmingham, AL, 6San Diego VA/UCSD, San Diego, CA

    Background/Purpose: Gout encompasses acute arthritis flares mediated by innate autoinflammatory responses to urate crystals, chronic granulomatous tophi, and synovitis promoting bone erosion and soft tissue…
  • Abstract Number: 1938 • 2019 ACR/ARP Annual Meeting

    The Pre-pregnancy Rheumatoid Arthritis Gene Expression Signature Correlates with Improvement or Worsening of Disease Activity During Pregnancy: A Pilot Study

    Amogh Pathi 1, Mette Smed 2, Lior Pachter 3, Elizabeth Purdom 4, Matthew Wright 5, Nicholas Jewell 4, J. Lee Nelson 6, Jørn Olsen 7, Merete Lund Hetland 8, Vibeke Zoffmann 9 and Damini Jawaheer10, 1UCSF Benioff Children's Hospital Oakland, Oakland, 2Juliane Marie Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark, 3Caltech, Pasadena, 4University of California Berkeley, Berkeley, 5UCSF Benioff Children's Hopsital Oakland, Oakland, 6Fred Hutchinson Cancer Research Center, Seattle, 7Aarhus University Hospital, Aarhus, Denmark, 8DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark, 9Juliane Marie Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, 10UCSF Benioff Children's Hospital Oakland, Oakland, CA

    Background/Purpose: Pregnancy is known to induce a natural improvement of Rheumatoid Arthritis (RA) symptoms in 50-75% of patients as gestation progresses. However, the underlying mechanisms…
  • Abstract Number: 1939 • 2019 ACR/ARP Annual Meeting

    Analysis of Discoid Lupus Erythematosus (DLE) Gene Expression Reveals Dysregulation of Pathogenic Pathways Associated with Infiltrating Immune/Inflammatory Cells

    Frances Harris1, Sarah Heuer 2, Robert Robl 2, Prathyusha Bachali 2, Adam Labonte 2, Benjamin Chong 3, Michelle Catalina 2, Peter Lipsky 2 and Amrie Grammer 2, 1RILITE Research Institute, Charlottesville, VA, 2RILITE Research Institute, Charlottesville, 3University of Texas Southwestern, Dallas

    Background/Purpose: DLE is a chronic, scarring inflammatory autoimmune disease of the skin. The precise molecular pathways underlying DLE pathogenesis have not been fully delineated. To…
  • Abstract Number: 1940 • 2019 ACR/ARP Annual Meeting

    Investigating the Post-Partum Flare in Rheumatoid Arthritis Using Transcriptome Analysis

    Matthew Wright1, Dana Goin 2, Mette Smed 3, Lior Pachter 4, J. Lee Nelson 5, Nicholas Jewell 6, Jørn Olsen 7, Merete Lund Hetland 8, Vibeke Zoffmann 9 and Damini Jawaheer 10, 1UCSF Benioff Children's Hopsital Oakland, Oakland, 2UCSF Benioff Children's Hospital Oakland, Oakland, 3Juliane Marie Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark, 4Caltech, Pasadena, 5Fred Hutchinson Cancer Research Center, Seattle, 6University of California Berkeley, Berkeley, 7Aarhus University Hospital, Aarhus, Denmark, 8DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark, 9Juliane Marie Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, 10UCSF Benioff Children's Hospital Oakland, Oakland, CA

    Background/Purpose: Women with Rheumatoid arthritis (RA) tend to have a predictable flare of disease activity in the months after childbirth. The mechanism(s) underlying this post-partum…
  • Abstract Number: 1941 • 2019 ACR/ARP Annual Meeting

    Interactions Between Genome-Wide Genetic Factors and Current Smoking in Determining SLE Risk

    Jing Cui1, Soumya Raychaudhuri 2, Cameron Speyer 2, Susan Malspeis 2, Hongshu Guan 3, Xinyi Liu 2, Jessica Williams 2, Emma Davenport 4, Rachel Knevel 5, Elizabeth Karlson 2 and Karen Costenbader 2, 1Brigham Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women's Hospital, Boston, 4Sanger Institute, Cambridge, United Kingdom, 5Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: We have previously reported that current smoking (or having recently quit within 4 years) was associated with elevated risk of SLE, in particular anti-dsDNA+…
  • Abstract Number: 1942 • 2019 ACR/ARP Annual Meeting

    Genome-wide Association Study in a Japanese Population Revealed Novel Candidate Genes for Antineutrophil Cytoplasmic Antibody-associated Vasculitis

    Masayoshi Harigai1, Aya Kawasaki 2, Naoyuki Tsuchiya 2, Ken-Ei Sada 3, Fumio Hirano 4, Takahiko Sugihara 5, Koichi Amano 6, Kunihiro Yamagata 7, Hiroaki Dobashi 8, Kenji Nagasaka 9, Tatsuya Atsumi 10, Seik-Soon Khor 11, Katsushi Tokunaga 12, Shoichi Ozaki 13, Seiichi Matsuo 14, Yoshihiro Arimura 15 and Hirofumi Makino 16, 1Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan, 2Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 3Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 4Department of Rheumatology, Tokyo Medical and Dental University, Tokyo, Japan, 5Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 6Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Kawagoe, Japan, 7Department of Nephrology, University of Tsukuba, Tsukuba, Ibaraki, Japan, 8Kagawa University, Kagawa, Japan, 9Department of Rheumatology, Ome Municipal General Hospital, Ome, Japan, 10Hokkaido University, Sapporo, Japan, 11Genome Medical Science Project (Toyama), National Center for Global Health and Medicine, Tokyo, Japan, 12National Center for Global Health and Medicine, Tokyo, Japan, 13St. Marianna University School of Medicine, Kawasaki, Japan, 1413. Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan, 15Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan, 16Okayama University, Okayama, Japan

    Background/Purpose: Clinical and serological features of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are different across geographical regions and ethnicities, which strongly indicates significant roles of…
  • Abstract Number: 1943 • 2019 ACR/ARP Annual Meeting

    The Emerging Regulatory Function of microRNA146a in Bone Biology and Osteoporosis

    Victoria Saferding1, Melanie Hofmann 2, Julia S. Brunner 2, Mihaela F. Militaru 2, Antonia Puchner 2, Silvia Hayer 2, Melanie Timmen 3, Richard Stange 3, Josef Smolen 2 and Stephan Blüml 4, 1Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, 2Medical University of Vienna, Vienna, Austria, 3University Hospital Muenster, Muenster, Germany, 4Medical University of Vienna, Vienna

    Background/Purpose: Micro RNAs (miRNAs) play a crucial role in the regulation of bone metabolism. MiR-146a, an important anti-inflammatory miRNA, was found to negatively impact osteogenesis…
  • Abstract Number: 1944 • 2019 ACR/ARP Annual Meeting

    Two Biomarkers with Predictive Capacity to Diagnosis Pre-Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative

    María Camacho-Encina1, Vanesa Balboa-Barreiro 2, Rocío Paz-González 3, Valentina Calamia 3, Lucía Lourido 4, Patricia Fernández-Puente 3, Cristina Ruiz-Romero 5 and Francisco J. Blanco 6, 1Proteomics Group-ProteoRed/ISCIII, Grupo de Investigación de Reumatología (GIR), INIBIC – Hospital Universitario de A Coruña, A Coruña, Spain., A Coruña, Spain, 2Grupo de Investigación de Reumatología (GIR), INIBIC-Hospital Universitario de A Coruña, A Coruña, Spain, A Coruña, Galicia, Spain, 3Proteomics Group, Rheumatology Division, ProteoRed, PRB2-ISCIII. INIBIC-Hospital Universitario A Coruña,15006 A Coruña-Spain, A Coruña, Galicia, Spain, 4Proteomics Group-ProteoRed/ISCIII, RIER, Grupo de Investigación de Reumatología (GIR), INIBIC – Hospital Universitario de A Coruña, A Coruña, Spain., A Coruña, Spain, 5Proteomics Group-ProteoRed/ISCIII, CIBER-BBN, Grupo de Investigación de Reumatología (GIR), INIBIC – Hospital Universitario de A Coruña, A Coruña, Spain., A Coruña, Spain, 6Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain

    Background/Purpose: Osteoarthritis (OA) is the most prevalent rheumatic disorder of the middle-age population. The lack of sensitive diagnostics methods led to an identification of the…
  • Abstract Number: 1945 • 2019 ACR/ARP Annual Meeting

    Polymorphisms in Genes Involved in Methotrexate Pathway: Predictor of Response to Methotrexate Therapy in Indian Rheumatoid Arthritis Patients

    Ankita Singh1, Harikrishnan Nair 2, Vikas Gupta 2, Pradeepta Sekhar 2, Ramnath Misra 3 and Amita Aggarwal 4, 1Sanjay Gandhi Post Graduate institute of medical science, Lucknow, India, Lucknow, Uttar Pradesh, India, 2Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 3Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Lucknow, Uttar Pradesh, India, 4Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, Lucknow, Uttar Pradesh, India

    Background/Purpose: Methotrexate (MTX) is first line therapy to treat rheumatoid arthritis (RA) patients. However, the response is variable with 50-60% showing response and this variability…
  • Abstract Number: 1946 • 2019 ACR/ARP Annual Meeting

    Metabolic Regulation in Cybrids Obtained from Healthy and Osteoarthritic (OA) Patients: Impaired Metabolic Flexibility in OA Process

    Andrea Dalmao-Fernández1, Jenny Lund 2, Tamara Hermida-Gómez 3, María E. Vázquez-Mosquera 1, Ignacio Rego-Pérez 4, Francisco J. Blanco 4 and Mercedes Fernandez-Moreno 5, 1Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Galicia, Spain, 2Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway, 3Unidad de Bioingeniería Tisular y Terapia Celular (GBTTC-CHUAC). Grupo de Investigación en Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC). Sergas. Centro de Investigaciones Científicas Avanzadas (CICA), A Coruña, Spain, 4Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain, 5Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España. CIBER-BBM, A Coruña, Spain

    Background/Purpose: Background: Osteoarthritis (OA) is the most frequent joint disease.The OA is a heterogeneous disorder. With acceptance of the joint as an organ, the pathogenesis…
  • Abstract Number: 1947 • 2019 ACR/ARP Annual Meeting

    Integrating Genetic Risk Scores and Pre-Diagnostic Metabolomics to Infer Dysregulated Mechanisms in Rheumatoid Arthritis in Women

    Su H. Chu1, Jing Cui 2, Jeffrey Sparks 2, Bing Lu 2, Clary Clish 3, Jessica Lasky-Su 1, Elizabeth Karlson 2 and Karen Costenbader 2, 1Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Broad Institute of MIT and Harvard, Boston, MA

    Background/Purpose: Rheumatoid arthritis genetic risk scores (RA-GRS) improve RA risk prediction, but the added predictive value over lifestyle risk factors is modest. Several human leukocyte…
  • « Previous Page
  • 1
  • …
  • 1067
  • 1068
  • 1069
  • 1070
  • 1071
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology